Clearstead Advisors’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$263K Sell
1,190
-2,312
-66% -$566K ﹤0.01% 909
2025
Q4
$888K Buy
3,502
+1,595
+84% +$401K 0.01% 509
2025
Q3
$472K Buy
1,907
+298
+19% +$71.3K 0.01% 651
2025
Q2
$386K Buy
1,609
+270
+20% +$62.9K 0.01% 677
2025
Q1
$303K Sell
1,339
-3,064
-70% -$674K ﹤0.01% 705
2024
Q4
$905K Sell
4,403
-4,483
-50% -$983K 0.01% 430
2024
Q3
$2.16M Sell
8,886
-902
-9% -$211K 0.03% 288
2024
Q2
$2.15M Sell
9,788
-452
-4% -$98.2K 0.04% 269
2024
Q1
$2.38M Sell
10,240
-1,542
-13% -$348K 0.12% 139
2023
Q4
$2.59M Sell
11,782
-11,810
-50% -$2.5M 0.14% 126
2023
Q3
$5.18M Buy
23,592
+11,692
+98% +$2.64M 0.15% 115
2023
Q2
$2.68M Sell
11,900
-2
-0% -$400 0.16% 106
2023
Q1
$2.28M Buy
11,902
+2
+0% +$387 0.17% 108
2022
Q4
$2.2M Sell
11,900
-14,500
-55% -$2.55M 0.17% 106
2022
Q3
$4.39M Hold
26,400
0.4% 56
2022
Q2
$5.44M Hold
26,400
0.42% 54
2022
Q1
$6.38M Buy
26,400
+4,940
+23% +$1.15M 0.43% 49
2021
Q4
$5.22M Sell
21,460
-123
-0.6% -$28.1K 0.36% 58
2021
Q3
$4.41M Sell
21,583
-4,889
-18% -$1.05M 0.33% 63
2021
Q2
$5.46M Buy
26,472
+12
+0% +$2.42K 0.42% 53
2021
Q1
$5.04M Buy
26,460
+800
+3% +$148K 0.42% 55
2020
Q4
$4.86M Sell
25,660
-12,488
-33% -$2.33M 0.44% 51
2020
Q3
$6.72M Hold
38,148
0.72% 31
2020
Q2
$5.85M Hold
38,148
0.68% 36
2020
Q1
$5.34M Buy
38,148
+13,419
+54% +$2.01M 0.78% 28
2019
Q4
$3.77M Buy
+24,729
New +$3.62M 0.46% 56

Other funds holding STE

Clearstead Advisors's STE Position: Q1 2026 in Review

Clearstead Advisors reduced its Steris (STE) stake by 66% in Q1 2026, selling an estimated $566K and leaving 1,190 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #909.

Clearstead Advisors first reported a position in STE in Q4 2019 and has held it in 26 quarters since. The position peaked at $6.72M in Q3 2020. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Clearstead Advisors held 1,190 shares of Steris worth $263K as of Q1 2026.
  • Clearstead Advisors sold 2,312 Steris shares in Q1 2026, an estimated $566K.
  • Steris made up ﹤0.01% of Clearstead Advisors's portfolio in Q1 2026, its #909 holding.
  • Clearstead Advisors first reported a position in Steris in Q4 2019 and has held it in 26 quarters since.
  • Clearstead Advisors's Steris position peaked at $6.72M in Q3 2020.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Clearstead Advisors's 13F filing for Q1 2026, filed 6 May 2026.